skip to Main Content
blank

Trump Mary 17 No. 17 Non-Indians to cut prices in the US; Dips Pharma Nifty

By 1 August, most trade offers will be completed: Donald TrumpIans residents

The letter from the US President He asked global prices in the country, as its effects hit the Indian stock market as well.

The letter requires these businesses that cut the United States to match the price in other developed market prices.

blank

Open A/C With Motilal Oswal

Upto 4X Margin Funding in Equity

Free Account Opening

Although your pharmaceutical company receives Trump’s letter, effective Pharma index, decrease 2.45 percent during Friday.

The benchmark fell for a third day in a row. Industry to produce Sun Sun decay declined 3.98 percent. Aurobindo Pharma lost 3.42 percent and Indian granules lost 3.2 percent. Gland Pharma, Cipla, and Lupine fell 2 to 3 percent.

The US president wrote to 17 of the world’s pharmaceutical company, press it as low dosing prices immediately and costs in other countries.

The font was sent to Eli Lilly, nomodo Nordisk, pfizer, etc., finding our best favor within 60 days.

Trump Mary 17 No. 17 Non-Indians to cut prices in the US; Dips Pharma NiftyIans residents

The White Leavitt Leavittist said that the previous information shows that Americans paid more than more famous drugs.

The Trump previously announced 12 May 12, ask Pharma companies to cut the price in the US. Industrial Sources in India says that your Trump may cause an Indian brand with the Indian brand to the United States, generally sold at low prices. If the price is further cut, it will make an unavoidable transportation, they speak. A third of US drug exports to US $ 30 billion in the US market.

Trump has given 60 days drug companies to voluntish with Diktat diktat in the letter ,,

Trump’s required companies that need some direct drugs with patients at the price they are offered a person’s insurance.

(With raw materials from Ians)

Related Articles

The opinions and investment advice provided by experts on ipogmp.org are solely their own and do not reflect the views of the website or its management. Ipogmp.org recommends that users consult with certified professionals before making any investment decisions. *Please note that advisory services mentioned on Ipogmp.org are not currently operational and are proposed services awaiting SEBI registration.

This Post Has 0 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Back To Top